Literature DB >> 3877008

A case-control study of BCG and childhood tuberculosis in Cali, Colombia.

C Shapiro, N Cook, D Evans, W Willett, I Fajardo, D Koch-Weser, G Bergonzoli, O Bolanos, R Guerrero, C H Hennekens.   

Abstract

We conducted a case-control study to evaluate the effectiveness of BCG vaccination in preventing childhood tuberculosis (TB) in Cali, Colombia. We ascertained 178 cases aged 0 to 14 years from the respiratory clinics with cough or fever for at least three weeks and a positive chest X-ray for TB, as well as 320 controls who were from the same households but had no symptoms and negative X-rays. Using matched set multiple logistic regression analysis, we found the age- and sex-adjusted relative risk (RR) of TB among vaccinees compared with non-vaccinees to be 0.84 with 95% confidence limits (CL) from 0.43 to 1.62. There was, however, a significantly lowered relative risk of TB with increasing time since vaccination (RR = 0.83 per year since time of vaccination with 95% CL from 0.74 to 0.94.)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877008     DOI: 10.1093/ije/14.3.441

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  5 in total

1.  Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety.

Authors:  J B Milstien; J J Gibson
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Effectiveness of BCG vaccination against tuberculous meningitis: a case-control study in São Paulo, Brazil.

Authors:  V Wünsch Filho; E A de Castilho; L C Rodrigues; S R Huttly
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Evaluating primary prevention programmes against cancer.

Authors:  J A Hanley
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

4.  Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guérin (BCG) vaccines from different sources, Kazakhstan.

Authors:  Michael Favorov; Mohammad Ali; Aigul Tursunbayeva; Indira Aitmagambetova; Paul Kilgore; Shakhimurat Ismailov; Terence Chorba
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

5.  Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.

Authors:  Joaquim C V D Van-Dunem; Laura C Rodrigues; Luiz Claudio Arraes Alencar; Maria de Fátima Pessoa Militão-Albuquerque; Ricardo Arraes de Alencar Ximenes
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.